Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients.

MLA

Levin-Epstein, Rebecca, et al. “Prostate-Specific Antigen Kinetics and Biochemical Control Following Stereotactic Body Radiation Therapy, High Dose Rate Brachytherapy, and Low Dose Rate Brachytherapy: A Multi-Institutional Analysis of 3502 Patients.” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, vol. 151, Oct. 2020, pp. 26–32. EBSCOhost, https://doi.org/10.1016/j.radonc.2020.07.014.

APA

Levin-Epstein, R., Cook, R. R., Wong, J. K., Stock, R. G., Jeffrey Demanes, D., Collins, S. P., Aghdam, N., Suy, S., Mantz, C., Katz, A. J., Nickols, N. G., Miszczyk, L., Napieralska, A., Namysl-Kaletka, A., Prionas, N. D., Bagshaw, H., Buyyounouski, M. K., Cao, M., Mahal, B. A., … Kishan, A. U. (2020). Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 151, 26–32. https://doi.org/10.1016/j.radonc.2020.07.014

Chicago

Levin-Epstein, Rebecca, Ryan R Cook, J Karen Wong, Richard G Stock, D Jeffrey Demanes, Sean P Collins, Nima Aghdam, et al. 2020. “Prostate-Specific Antigen Kinetics and Biochemical Control Following Stereotactic Body Radiation Therapy, High Dose Rate Brachytherapy, and Low Dose Rate Brachytherapy: A Multi-Institutional Analysis of 3502 Patients.” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology 151 (October): 26–32. doi:10.1016/j.radonc.2020.07.014.